CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma
- 18 May 2010
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 37 (7) , 737-743
Abstract
CD10 is now commonly used to differentiate atypical fibroxanthoma (AFX) from melanoma, spindle cell and dedifferentiated variants of squamous cell carcinoma and leiomyosarcoma. However, we have encountered CD10‐positive tumors that mimicked AFX but proved to be myxofibrosarcomas. The purpose of this study was to evaluate CD10 expression in a wide range of mesenchymal neoplasms that may involve the skin using tissue microarrays. Our results indicate that in addition to AFX, CD10 expression is common in myxofibrosarcomas, undifferentiated pleomorphic sarcomas, dermatofibromas and dermatofibrosarcoma protuberans. Myxofibrosarcomas commonly present in the skin and may be difficult to distinguish from AFX on small biopsies and CD10 positivity may confound the diagnostic difficulty.Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF. CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.Keywords
This publication has 12 references indexed in Scilit:
- Myxoid atypical fibroxanthoma: a previously undescribed variantJournal of Cutaneous Pathology, 2009
- Myxofibrosarcoma in the skinJournal of Cutaneous Pathology, 2008
- Evaluation of CD10 and Procollagen 1 Expression in Atypical Fibroxanthoma and DermatofibromaAmerican Journal of Surgical Pathology, 2008
- Immunohistochemical staining of CD10 in atypical fibroxanthomasJournal of Cutaneous Pathology, 2006
- Primary Cutaneous Myxofibrosarcoma Mimicking Pleomorphic Hyalinizing Angiectatic Tumor (PHAT)The American Journal of Dermatopathology, 2005
- Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two casesJournal of Cutaneous Pathology, 2005
- CD10, a Useful Marker for Atypical FibroxanthomasThe American Journal of Dermatopathology, 2005
- CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progressionLaboratory Investigation, 2004
- Paraffin-Section Detection of CD10 in 505 Nonhematopoietic NeoplasmsAmerican Journal of Clinical Pathology, 2000
- Expression of CALLA/CD10 on human melanoma cellsMelanoma Research, 1993